Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: (Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling

Fig. 3

Effects of GST, GST SH2 Wt, GST SH2 TrM, (Arg)9-GST, (Arg)9-GST SH2 Wt and (Arg)9-GST SH2 TrM on the proliferation of B16F10 cells. Cells were treated with different GST-fused proteins or PBS (as control) at different concentrations (a) (0.5, 1, 2, 4 and 8 μM) for various time (b) (1,2,4 and 8 h) and cell viability was measured by MTT assay (n = 3, *P < 0.05)

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us